Microfluidic Chip with Low Constant-Current Stimulation (LCCS) Platform: Human Nucleus Pulposus Degeneration In Vitro Model for Symptomatic Intervertebral Disc

Intervertebral disc (IVD) degeneration is a major cause of low back pain (LBP) in the lumbar spine. This phenomenon is caused by several processes, including matrix degradation in IVD tissues, which is mediated by matrix metalloproteinases (MMPs) and inflammatory responses, which can be mediated by...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: An-Gi Kim, Tae-Won Kim, Woo-Keun Kwon, Kwang-Ho Lee, Sehoon Jeong, Min-Ho Hwang, Hyuk Choi
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/5202d49da5124b0692bdada96712d4bf
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5202d49da5124b0692bdada96712d4bf
record_format dspace
spelling oai:doaj.org-article:5202d49da5124b0692bdada96712d4bf2021-11-25T18:22:49ZMicrofluidic Chip with Low Constant-Current Stimulation (LCCS) Platform: Human Nucleus Pulposus Degeneration In Vitro Model for Symptomatic Intervertebral Disc10.3390/mi121112912072-666Xhttps://doaj.org/article/5202d49da5124b0692bdada96712d4bf2021-10-01T00:00:00Zhttps://www.mdpi.com/2072-666X/12/11/1291https://doaj.org/toc/2072-666XIntervertebral disc (IVD) degeneration is a major cause of low back pain (LBP) in the lumbar spine. This phenomenon is caused by several processes, including matrix degradation in IVD tissues, which is mediated by matrix metalloproteinases (MMPs) and inflammatory responses, which can be mediated by interactions among immune cells, such as macrophages and IVD cells. In particular, interleukin (IL)-1 beta (β), which is a master regulator secreted by macrophages, mediates the inflammatory response in nucleus pulposus cells (NP) and plays a significant role in the development or progression of diseases. In this study, we developed a custom electrical stimulation (ES) platform that can apply low-constant-current stimulation (LCCS) signals to microfluidic chips. Using this platform, we examined the effects of LCCS on IL-1β-mediated inflammatory NP cells, administered at various currents (5, 10, 20, 50, and 100 μA at 200 Hz). Our results showed that the inflammatory response, induced by IL-1β in human NP cells, was successfully established. Furthermore, 5, 10, 20, and 100 μA LCCS positively modulated inflamed human NP cells’ morphological phenotype and kinetic properties. LCCS could affect the treatment of degenerative diseases, revealing the applicability of the LCCS platform for basic research of electroceuticals.An-Gi KimTae-Won KimWoo-Keun KwonKwang-Ho LeeSehoon JeongMin-Ho HwangHyuk ChoiMDPI AGarticlemicrofluidic chipelectrical stimulationlow constant-current stimulationintervertebral disc degenerationinflammationMechanical engineering and machineryTJ1-1570ENMicromachines, Vol 12, Iss 1291, p 1291 (2021)
institution DOAJ
collection DOAJ
language EN
topic microfluidic chip
electrical stimulation
low constant-current stimulation
intervertebral disc degeneration
inflammation
Mechanical engineering and machinery
TJ1-1570
spellingShingle microfluidic chip
electrical stimulation
low constant-current stimulation
intervertebral disc degeneration
inflammation
Mechanical engineering and machinery
TJ1-1570
An-Gi Kim
Tae-Won Kim
Woo-Keun Kwon
Kwang-Ho Lee
Sehoon Jeong
Min-Ho Hwang
Hyuk Choi
Microfluidic Chip with Low Constant-Current Stimulation (LCCS) Platform: Human Nucleus Pulposus Degeneration In Vitro Model for Symptomatic Intervertebral Disc
description Intervertebral disc (IVD) degeneration is a major cause of low back pain (LBP) in the lumbar spine. This phenomenon is caused by several processes, including matrix degradation in IVD tissues, which is mediated by matrix metalloproteinases (MMPs) and inflammatory responses, which can be mediated by interactions among immune cells, such as macrophages and IVD cells. In particular, interleukin (IL)-1 beta (β), which is a master regulator secreted by macrophages, mediates the inflammatory response in nucleus pulposus cells (NP) and plays a significant role in the development or progression of diseases. In this study, we developed a custom electrical stimulation (ES) platform that can apply low-constant-current stimulation (LCCS) signals to microfluidic chips. Using this platform, we examined the effects of LCCS on IL-1β-mediated inflammatory NP cells, administered at various currents (5, 10, 20, 50, and 100 μA at 200 Hz). Our results showed that the inflammatory response, induced by IL-1β in human NP cells, was successfully established. Furthermore, 5, 10, 20, and 100 μA LCCS positively modulated inflamed human NP cells’ morphological phenotype and kinetic properties. LCCS could affect the treatment of degenerative diseases, revealing the applicability of the LCCS platform for basic research of electroceuticals.
format article
author An-Gi Kim
Tae-Won Kim
Woo-Keun Kwon
Kwang-Ho Lee
Sehoon Jeong
Min-Ho Hwang
Hyuk Choi
author_facet An-Gi Kim
Tae-Won Kim
Woo-Keun Kwon
Kwang-Ho Lee
Sehoon Jeong
Min-Ho Hwang
Hyuk Choi
author_sort An-Gi Kim
title Microfluidic Chip with Low Constant-Current Stimulation (LCCS) Platform: Human Nucleus Pulposus Degeneration In Vitro Model for Symptomatic Intervertebral Disc
title_short Microfluidic Chip with Low Constant-Current Stimulation (LCCS) Platform: Human Nucleus Pulposus Degeneration In Vitro Model for Symptomatic Intervertebral Disc
title_full Microfluidic Chip with Low Constant-Current Stimulation (LCCS) Platform: Human Nucleus Pulposus Degeneration In Vitro Model for Symptomatic Intervertebral Disc
title_fullStr Microfluidic Chip with Low Constant-Current Stimulation (LCCS) Platform: Human Nucleus Pulposus Degeneration In Vitro Model for Symptomatic Intervertebral Disc
title_full_unstemmed Microfluidic Chip with Low Constant-Current Stimulation (LCCS) Platform: Human Nucleus Pulposus Degeneration In Vitro Model for Symptomatic Intervertebral Disc
title_sort microfluidic chip with low constant-current stimulation (lccs) platform: human nucleus pulposus degeneration in vitro model for symptomatic intervertebral disc
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/5202d49da5124b0692bdada96712d4bf
work_keys_str_mv AT angikim microfluidicchipwithlowconstantcurrentstimulationlccsplatformhumannucleuspulposusdegenerationinvitromodelforsymptomaticintervertebraldisc
AT taewonkim microfluidicchipwithlowconstantcurrentstimulationlccsplatformhumannucleuspulposusdegenerationinvitromodelforsymptomaticintervertebraldisc
AT wookeunkwon microfluidicchipwithlowconstantcurrentstimulationlccsplatformhumannucleuspulposusdegenerationinvitromodelforsymptomaticintervertebraldisc
AT kwangholee microfluidicchipwithlowconstantcurrentstimulationlccsplatformhumannucleuspulposusdegenerationinvitromodelforsymptomaticintervertebraldisc
AT sehoonjeong microfluidicchipwithlowconstantcurrentstimulationlccsplatformhumannucleuspulposusdegenerationinvitromodelforsymptomaticintervertebraldisc
AT minhohwang microfluidicchipwithlowconstantcurrentstimulationlccsplatformhumannucleuspulposusdegenerationinvitromodelforsymptomaticintervertebraldisc
AT hyukchoi microfluidicchipwithlowconstantcurrentstimulationlccsplatformhumannucleuspulposusdegenerationinvitromodelforsymptomaticintervertebraldisc
_version_ 1718411256089542656